Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.

The intestine-specific homeobox transcription factor intestine-specific homeobox (ISX) is an IL6-inducible proto-oncogene implicated in the development of hepatocellular carcinoma, but its mechanistic contributions to this process are undefined. In this study, we provide evidence that ISX mediates a positive feedback loop integrating inflammation, tryptophan catabolism, and immune suppression. We found that ISX-mediated IL6-induced expression of the tryptophan catabolic enzymes Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase in hepatocellular carcinoma cells, resulting in an ISX-dependent increase in the tryptophan catabolite kynurenine and its receptor aryl hydrocarbon receptor (AHR). Activation of this kynurenine/AHR signaling axis acted through a positive feedback mechanism to increase ISX expression and enhance cellular proliferation and tumorigenic potential. RNAi-mediated attenuation of ISX or AHR reversed these effects. In an IDO1-dependent manner, ectopic expression of ISX induced expression of genes encoding the critical immune modulators CD86 (B7-2) and programmed death ligand-1 (PD-L1), through which ISX conferred a significant suppressive effect on the CD8+ T-cell response. In hepatocellular carcinoma specimens, expression of IDO1, kynurenine, AHR, and PD-L1 correlated negatively with survival. Overall, our results identified a feed-forward mechanism of immune suppression in hepatocellular carcinoma organized by ISX, which involves kynurenine-AHR signaling and PD-L1, offering insights into immune escape by hepatocellular carcinoma, which may improve its therapeutic management. Cancer Res; 77(15); 4065-77. ©2017 AACR.

[1]  C. Chai,et al.  Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma , 2016, Oncotarget.

[2]  C. Chai,et al.  Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC , 2016, Oncotarget.

[3]  A. Ribas,et al.  Combination cancer immunotherapies tailored to the tumour microenvironment , 2016, Nature Reviews Clinical Oncology.

[4]  M. Karin,et al.  Immunity, inflammation, and cancer: an eternal fight between good and evil. , 2015, The Journal of clinical investigation.

[5]  P. Verhoest,et al.  Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway. , 2015, Journal of medicinal chemistry.

[6]  F. Balkwill,et al.  Inflammation and cancer: advances and new agents , 2015, Nature Reviews Clinical Oncology.

[7]  L. Rendina,et al.  Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy. , 2015, Drug discovery today.

[8]  E. Wagner,et al.  Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. , 2014, Cancer cell.

[9]  C. Orabona,et al.  AhR-Mediated, Non-Genomic Modulation of IDO1 Function , 2014, Front. Immunol..

[10]  M. Geffard,et al.  Aryl hydrocarbon receptor control of a disease tolerance defence pathway , 2014, Nature.

[11]  P. Vineis,et al.  Global cancer patterns: causes and prevention , 2014, The Lancet.

[12]  Nan Hao,et al.  The emerging roles of AhR in physiology and immunity. , 2013, Biochemical pharmacology.

[13]  Soyoung Lee,et al.  Aryl hydrocarbon receptor-mediated induction of the microRNA-132/212 cluster promotes interleukin-17–producing T-helper cell differentiation , 2013, Proceedings of the National Academy of Sciences.

[14]  Zi-yu Liu,et al.  AhR expression is increased in hepatocellular carcinoma , 2013, Journal of Molecular Histology.

[15]  C. Chai,et al.  Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma. , 2013, Cancer research.

[16]  W. Wick,et al.  Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. , 2012, Cancer research.

[17]  G. Perdew,et al.  Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element‐independent manner , 2012, Hepatology.

[18]  L. Qin,et al.  Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma , 2012, International journal of cancer.

[19]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[20]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[21]  Russell S. Thomas,et al.  Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. , 2010, Molecular endocrinology.

[22]  S. Safe,et al.  The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. , 2009, Endocrine-related cancer.

[23]  Alvaro Puga,et al.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. , 2009, Biochemical pharmacology.

[24]  F. Matsumura,et al.  Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. , 2008, Biochemical and biophysical research communications.

[25]  Xiaoqing Chang,et al.  The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. , 2008, Molecular biology of the cell.

[26]  G. Prendergast,et al.  Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. , 2007, Cancer research.

[27]  Sarah J. Thackray,et al.  Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase , 2007, Proceedings of the National Academy of Sciences.

[28]  R. Schreiber,et al.  Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.

[29]  J. Thomsen,et al.  Aryl hydrocarbon (Ah) nonresponsiveness in estrogen receptor-negative MDA-MB-231 cells is associated with expression of a variant arnt protein. , 1997, Archives of biochemistry and biophysics.

[30]  M. Levine,et al.  Homeobox proteins as sequence-specific transcription factors , 1988, Cell.

[31]  M. D. Meek,et al.  Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription. , 1999, Environmental research.

[32]  G. Boivin,et al.  Molecular and Cellular Pathobiology the Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis , 2022 .